Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Feigin

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Neurology|December 12, 2001
Metabolic correlates of levodopa response in Parkinson's diseaseA Feigin, M Fukuda, V Dhawan, et al.
Brain : a Journal of Neurology|September 26, 2007
Thalamic metabolism and symptom onset in preclinical Huntington's diseaseA Feigin, C Tang, Y Ma, et al.
Journal of Medical Genetics|November 1, 1994
Trinucleotide repeat length and progression of illness in Huntington's diseaseK Kieburtz, M MacDonald, C Shih, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 1, 1995
Functional decline in Huntington's diseaseA Feigin, K Kieburtz, K Bordwell, et al.
Parkinsonism & Related Disorders|March 5, 2008
Implicit and explicit aspects of sequence learning in pre-symptomatic Huntington's diseaseM F Ghilardi, G Silvestri, A Feigin, et al.
Neurology|April 1, 1996
A controlled trial of deprenyl in children with Tourette's syndrome and attention deficit hyperactivity disorderA Feigin, R Kurlan, M P McDermott, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 1, 1996
A controlled trial of remacemide hydrochloride in Huntington's diseaseK Kieburtz, A Feigin, M McDermott, et al.
Polymers|March 6, 2021
Hybrid Polycarbosilane-Siloxane Dendrimers: Synthesis and PropertiesSergey A Milenin, Elizaveta V Selezneva, Pavel A Tikhonov, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|August 21, 2008
Repeat instability in the 27-39 CAG range of the HD gene in the Venezuelan kindreds: Counseling implicationsD Brocklebank, J Gayán, J M Andresen, et al.
Neurology|January 26, 2006
Creatine in Huntington disease is safe, tolerable, bioavailable in brain and reduces serum 8OH2'dGS M Hersch, S Gevorkian, K Marder, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Neurology|December 12, 2001
Metabolic correlates of levodopa response in Parkinson's diseaseA Feigin, M Fukuda, V Dhawan, et al.
Brain : a Journal of Neurology|September 26, 2007
Thalamic metabolism and symptom onset in preclinical Huntington's diseaseA Feigin, C Tang, Y Ma, et al.
Journal of Medical Genetics|November 1, 1994
Trinucleotide repeat length and progression of illness in Huntington's diseaseK Kieburtz, M MacDonald, C Shih, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 1, 1995
Functional decline in Huntington's diseaseA Feigin, K Kieburtz, K Bordwell, et al.
Parkinsonism & Related Disorders|March 5, 2008
Implicit and explicit aspects of sequence learning in pre-symptomatic Huntington's diseaseM F Ghilardi, G Silvestri, A Feigin, et al.
Neurology|April 1, 1996
A controlled trial of deprenyl in children with Tourette's syndrome and attention deficit hyperactivity disorderA Feigin, R Kurlan, M P McDermott, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 1, 1996
A controlled trial of remacemide hydrochloride in Huntington's diseaseK Kieburtz, A Feigin, M McDermott, et al.
Polymers|March 6, 2021
Hybrid Polycarbosilane-Siloxane Dendrimers: Synthesis and PropertiesSergey A Milenin, Elizaveta V Selezneva, Pavel A Tikhonov, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|August 21, 2008
Repeat instability in the 27-39 CAG range of the HD gene in the Venezuelan kindreds: Counseling implicationsD Brocklebank, J Gayán, J M Andresen, et al.
Neurology|January 26, 2006
Creatine in Huntington disease is safe, tolerable, bioavailable in brain and reduces serum 8OH2'dGS M Hersch, S Gevorkian, K Marder, et al.
Pageof 5